Vaccine effectiveness: How do the COVID-19 vaccines compare to vaccines for other diseases?

Not yet a subscriber? Sign up free below.

Over the summer many experts were concerned that a possible COVID-19 vaccine might only be 50% effective, roughly similar to estimates of how effective the flu vaccine is. That is why the initial numbers reported by Pfizer-BioNTech and Moderna are particularly encouraging in the context of other vaccine efficacy rates.

Data from the CDC in this chart, which we've reproduced from Axios, compares the COVID-19 vaccines with those for other infectious diseases. If the 95% numbers turn out to be true and replicable then the COVID vaccines will rank among some of the most effective in modern medicine.

What does 95% effective mean?

Okay let's run some numbers using the Pfizer-BioNTech vaccine as an example. The trial involved 41,000 people, half were given the actual vaccine, half were given a placebo. At the end of the trial 170 cases of COVID-19 had been recorded in the total group. 162 of those were in the placebo group, and just 8 of them in the vaccine group. Hence the vaccinated group had 95% fewer infections = 95% effectiveness.

Not yet a subscriber? Sign up free below.

Tags

Stories from this newsletter

New kids on the bloc: 15 countries just signed the world's largest trade agreement
Vaccine effectiveness: How do the COVID-19 vaccines compare to vaccines for other diseases?
The blank cheque boom: How 2020 has been the year of the SPAC
We and our partners use cookies and similar technologies (“Cookies”) on our website and in our newsletters for performance, analytical or advertising purposes to ensure you have the best experience on our site and/or interaction with us. To find out more about the use of Cookies, see our Cookie Notice. Please click OK if you consent to our use of Cookies or click Manage my Preferences to manage your Cookie preferences.